epigallocatechin gallate has been researched along with Candidiasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Cánovas, F; Navarro-Martínez, MD; Rodríguez-López, JN | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Han, Y | 1 |
3 other study(ies) available for epigallocatechin gallate and Candidiasis
| Article | Year |
|---|---|
Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; Catechin; Drug Synergism; Enzyme Inhibitors; Ergosterol; Folic Acid; Folic Acid Antagonists; Fungal Proteins; Leucovorin; Microbial Sensitivity Tests; Models, Biological; Naphthalenes; S-Adenosylmethionine; Spectrum Analysis; Terbinafine; Tetrahydrofolate Dehydrogenase; Vitamin B Complex | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Catechin; Drug Synergism; Female; Hyphae; Mice; Mice, Inbred BALB C | 2007 |